Identifying disease modifying genes in multiple sclerosis

被引:100
作者
Kantarci, OH
de Andrade, M
Weinshenker, BG
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
multiple sclerosis; genetics; prognosis; severity; course; outcome;
D O I
10.1016/S0165-5728(01)00481-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evidence is mounting that genetic variation influences not only susceptibility to multiple sclerosis (MS), but also its course and severity. Identification of disease modifying genes, however, poses unique challenges, especially on how to classify the course and outcome of the disease in ways that may be relevant to analysis of biological factors that might be influenced by genes, The power of the statistical approaches to detect small effects of individual genes in complex disorders such as MS is problematic, and approaches to estimate power must be appropriate for the data. Nonetheless, using contemporary schemes of classification, genetic variants that influence disease course have been found; in fact, a small number have been confirmed to influence disease course in two or more independent studies. This review addresses strategies relevant to identification of disease modifying genes in MS, and summarizes and critically evaluates the cur-rent state of knowledge in this area. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:144 / 159
页数:16
相关论文
共 139 条
  • [1] Selected methodological issues in meiotic mapping of obesity genes in humans: Issues of power and efficiency
    Allison, DB
    Schork, NJ
    [J]. BEHAVIOR GENETICS, 1997, 27 (04) : 401 - 421
  • [2] Allison DB, 1997, AM J HUM GENET, V60, P676
  • [3] A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials
    Amato, MP
    Ponziani, G
    Bartolozzi, ML
    Siracusa, G
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 168 (02) : 96 - 106
  • [4] Relationship between tumour necrosis factor-alpha (TNFα) production and a specific multiple sclerosis (MS) associated TNF gene haplotype
    Armstrong, MA
    McDonnell, GV
    Graham, CA
    Kirk, CW
    Droogan, AG
    Hawkins, SA
    [J]. MULTIPLE SCLEROSIS, 1999, 5 (03): : 165 - 170
  • [5] CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis
    Barcellos, LF
    Schito, AM
    Rimmler, JB
    Vittinghoff, E
    Shih, A
    Lincoln, R
    Callier, S
    Elkins, MK
    Goodkin, DE
    Haines, JL
    Pericak-Vance, MA
    Hauser, SL
    Oksenberg, JR
    [J]. IMMUNOGENETICS, 2000, 51 (4-5) : 281 - 288
  • [6] Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis
    Bergsteinsdottir, K
    Yang, HT
    Pettersson, U
    Holmdahl, R
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (03) : 1564 - 1568
  • [7] BERR C, 1989, NEW ENGL J MED, V320, P467
  • [8] Familial factors influence disability in MS multiplex families
    Brassat, D
    Azais-Vuillemin, C
    Yaouanq, J
    Semana, G
    Reboul, J
    Cournu, I
    Mertens, C
    Edan, G
    Lyon-Caen, O
    Clanet, C
    Fontaine, B
    [J]. NEUROLOGY, 1999, 52 (08) : 1632 - 1636
  • [9] *BRIT DUTCH MULT S, 1988, J NEUROL NEUROSUR PS, V51, P412
  • [10] AGE OF ONSET IN SIBLINGS CONCORDANT FOR MULTIPLE-SCLEROSIS
    BULMAN, DE
    SADOVNICK, AD
    EBERS, GC
    [J]. BRAIN, 1991, 114 : 937 - 950